– Director of Brand Protection at Amgen, talks with GEN’s Editor-in-Chief John Sterling about Counterfeit Pharmaceuticals.

Previous articleBiofirms Develop Novel Therapeutics for MS
Next articleDr. Stephan Schuster from Penn State University and Dr. William Farmerie from the University of Florida at Gainsville